Patent Quality Initiative formed to file amicus briefs, petition for IPRs, educate

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Patent Quality Initiative formed to file amicus briefs, petition for IPRs, educate

Banking association and payments company The Clearing House has announced the formation of the Patent Quality Initiative (PQI), an advocacy organisation that will seek to promote strong patents and discourage the assertion of patents it believes are invalid

The organisation will undertake a number of strategic programmes including making pertinent prior art more easily accessible, providing educational research and briefings on the patent system and evolution of technology in financial services, and filing amicus briefs that highlight issues critical to patent quality.

PQI recently filed two amicus briefs urging courts to streamline the assessment of whether a patent is valid. The first amicus brief was in Ultramercial v Hulu and Wildtangent, while the second was in Intellectual Ventures v JPMC.

Additionally, PQI will petition the USPTO to conduct inter partes reviews (IPRs) on patents it believes are invalid. This ties in with a trend of organisations that are not directly involved in litigation filing petitions with the Patent Trial and Appeal Board. The Electronic Frontier Foundation last year filed an IPR to have a patent owned by Personal Audio invalidated, which was initiated in April this year. The Printing Industries of America also unsuccessfully filed IPRs against two patents owned by CTP Innovations.

Some firms that use membership fees to protect their members against non-practising entities also filed IPRs such as RPX and Unified Patents.

PQI is directed by Askeladden, a subsidiary of The Clearing House.

more from across site and SHARED ros bottom lb

More from across our site

Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Practitioners have welcomed extended funding of the specialist police unit until 2029, while the UKIPO says it is exploring increased scale
Abion says integration with Baylos marks an important step in the company’s international expansion plans
Via Licensing Alliance continues its China push as another smartphone manufacturer joins patent pool as licensee
Law firm mergers have the potential to reshape IP teams, and partners who were at the coalface of previous tie-ups say early coordination and flexibility can make the difference
Women are entering the IP profession, but still too few are being trusted with the clients, cases, and credit that may open the path to leadership
In other news, Australia’s IP office has announced expanded search options, and an EPO report shed light on slow progress relating to women inventors in Europe
Managing IP speaks with up-and-coming women lawyers at five law firms about fighting imposter syndrome, maintaining work-life balance and why real representation matters
Gift this article